Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download Microsoft EdgeDownload Microsoft Edge
Event

RSM - Recent developments in AI & digital health

February 24, 2020

AI is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care.

While AI has the potential to deliver significant health benefits, it is clear that there are some significant practical challenges, as well as ethical and regulatory considerations associated with the use of AI in healthcare.

Have we misunderstood disease?

Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK

Event

RSM - Recent developments in AI & digital health

February 24, 2020

AI is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care.

While AI has the potential to deliver significant health benefits, it is clear that there are some significant practical challenges, as well as ethical and regulatory considerations associated with the use of AI in healthcare.

Have we misunderstood disease?

Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK

Event

RSM - Recent developments in AI & digital health

RSM - Recent developments in AI & digital health

February 24, 2020

AI is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care.

While AI has the potential to deliver significant health benefits, it is clear that there are some significant practical challenges, as well as ethical and regulatory considerations associated with the use of AI in healthcare.

Have we misunderstood disease?

Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK

Event

RSM - Recent developments in AI & digital health

RSM - Recent developments in AI & digital health

24 February 2020

AI is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care.

While AI has the potential to deliver significant health benefits, it is clear that there are some significant practical challenges, as well as ethical and regulatory considerations associated with the use of AI in healthcare.

Have we misunderstood disease?

Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK

Arrange to meet us
Event

RSM - Recent developments in AI & digital health

February 24, 2020

AI is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care.

While AI has the potential to deliver significant health benefits, it is clear that there are some significant practical challenges, as well as ethical and regulatory considerations associated with the use of AI in healthcare.

Have we misunderstood disease?

Rabia Khan, PhD MBA
Chief of Translational Medicine, Sensyne Health, UK